VEGF siRNAs and AMD3100 are encapsulated in NPs targeting CXCR4 and delivered to liver fibrosis, inhibiting angiogenesis and HSCs activation to suppress the progression of fibrosis. The gene discussed is CXCR4; the disease is Hepatic fibrosis.